Clinical Trial Update: Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of anlotinib in advanced gastrointestinal stromal tumor after imatinib failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Cttq | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: UNKNOWN